keyword
https://read.qxmd.com/read/38647728/predicting-contralateral-extraprostatic-extension-in-unilateral-high-risk-prostate-cancer-a-multicentric-external-validation-study
#1
JOURNAL ARTICLE
Romain Diamand, Jean-Baptiste Roche, Vito Lacetera, Giuseppe Simone, Olivier Windisch, Daniel Benamran, Alexandre Fourcade, Georges Fournier, Gaelle Fiard, Guillaume Ploussard, Thierry Roumeguère, Alexandre Peltier, Simone Albisinni
PURPOSE: Accurate prediction of extraprostatic extension (EPE) is crucial for decision-making in radical prostatectomy (RP), especially in nerve-sparing strategies. Martini et al. introduced a three-tier algorithm for predicting contralateral EPE in unilateral high-risk prostate cancer (PCa). The aim of the study is to externally validate this model in a multicentric European cohort of patients. METHODS: The data from 208 unilateral high-risk PCa patients diagnosed through magnetic resonance imaging (MRI)-targeted and systematic biopsies, treated with RP between January 2016 and November 2021 at eight referral centers were collected...
April 22, 2024: World Journal of Urology
https://read.qxmd.com/read/38647689/the-impact-of-mpmri-targeted-vs-systematic-biopsy-on-the-risk-of-prostate-cancer-downgrading-at-final-pathology
#2
JOURNAL ARTICLE
G Sorce, A Stabile, F Pellegrino, E Mazzone, A Mattei, L Afferi, S Serni, A Minervini, M Roumiguiè, B Malavaud, M Valerio, A Rakauskas, G Marra, P Gontero, F Porpiglia, H Guo, J Zhuang, G Gandaglia, F Montorsi, A Briganti
PURPOSE: Although targeted biopsies (TBx) are associated with improved disease assessment, concerns have been raised regarding the risk of prostate cancer (PCa) overgrading due to more accurate biopsy core deployment in the index lesion. METHODS: We identified 1672 patients treated with radical prostatectomy (RP) with a positive mpMRI and ISUP ≥ 2 PCa detected via systematic biopsy (SBx) plus TBx. We compared downgrading rates at RP (ISUP 4-5, 3, and 2 at biopsy, to a lower ISUP) for PCa detected via SBx only (group 1), via TBx only (group 2), and eventually for PCa detected with the same ISUP 2-5 at both SBx and TBx (group 3), using multivariable logistic regression models (MVA)...
April 22, 2024: World Journal of Urology
https://read.qxmd.com/read/38645812/the-presence-of-cribriform-pattern-in-prostate-biopsy-and-radical-prostatectomy-is-associated-with-negative-postoperative-pathological-features
#3
JOURNAL ARTICLE
Rafal Osiecki, Mieszko Kozikowski, Łukasz Białek, Michał Pyzlak, Jakub Dobruch
INTRODUCTION: Prostate cancer is the second most common male cancer worldwide. Its rising incidence and high overtreatment rate drive the search for new prognostic factors. Histopathological variants, such as cribriform pattern (CP), are associated with poorer oncologic outcome. The aim of this study was to assess the correlation between CP in prostate biopsy and radical prostatectomy (RP) and postoperative pathological features. MATERIAL AND METHODS: In this retrospective, single-centre study we analysed the reviewed medical records of 100 men who underwent minimally invasive RP in the years 2017-2019...
2024: Central European Journal of Urology
https://read.qxmd.com/read/38645804/the-use-of-indocyanine-green-in-partial-nephrectomy-a-systematic-review
#4
REVIEW
Stamatios Katsimperis, Lazaros Tzelves, Themistoklis Bellos, Ioannis Manolitsis, Panagiotis Mourmouris, Nikolaos Kostakopoulos, Nikolaos Pyrgidis, Bhaskar Somani, Athanasios Papatsoris, Andreas Skolarikos
INTRODUCTION: The aim of this review was to assess the outcomes of partial nephrectomy using indocyanine green (ICG) regarding ischemia time, positive surgical margins (PSM), estimated blood loss (EBL) and estimated GFR reduction while also suggesting the optimal dosage scheme. MATERIAL AND METHODS: A systematic review was performed using Medline (PubMed), ClinicalTrials.gov, and Cochrane Library (CENTRAL) databases, in concordance with the PRISMA statement. Studies in English regarding the use of indocyanine green in partial nephrectomy were reviewed...
2024: Central European Journal of Urology
https://read.qxmd.com/read/38644731/-case-of-the-month-from-the-department-of-urology-oxford-university-hospitals-oxford-uk-stereotactic-radiotherapy-to-the-vas-deferens-for-psma-pet-ct-detected-local-recurrence-10%C3%A2-years-after-radical-prostatectomy
#5
Anthony S Bates, Abhishek D Sharma, Philip Camilleri, Lisa Browning, Clare Verrill, Freddie C Hamdy
No abstract text is available yet for this article.
April 22, 2024: BJU International
https://read.qxmd.com/read/38644624/advances-in-cancer-and-a-new-antibiotic-to-treat-complex-utis
#6
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
May 2024: BJU International
https://read.qxmd.com/read/38644155/effect-of-sex-on-the-oncological-outcomes-in-response-to-immunotherapy-and-antibody-drug-conjugates-in-patients-with-urothelial-and-kidney-cancer-a-systematic-review-and-a-network-meta-analysis
#7
REVIEW
Clara Cerrato, Fabio Crocerossa, Michele Marchioni, Gianluca Giannarini, Shilpa Gupta, Laurence Albiges, Oscar Brouwer, Maarten Albersen, Christian Fankhauser, Marc Oliver Grimm, Giorgio Gandaglia, Morgan Roupret, Maria Carmen Mir
BACKGROUND AND OBJECTIVE: Immune checkpoint inhibitors (ICIs) and antibody-drug conjugates (ADCs) herald a transformative era in metastatic renal cell carcinoma (RCC) and transitional cell carcinoma (TCC) treatment, amid acknowledged sex-based disparities in these cancers. We conducted a systematic review and network meta-analysis (NMA) to identify sex-specific differences in the efficacy of ICI/ADC monotherapy or combination therapies for RCC and TCC survival, in metastatic and adjuvant settings...
April 20, 2024: European Urology Oncology
https://read.qxmd.com/read/38644146/deep-and-durable-prostate-specific-antigen-response-to-darolutamide-with-androgen-deprivation-therapy-and-docetaxel-and-association-with-clinical-outcomes-for-patients-with-high-or-low-volume-metastatic-hormone-sensitive-prostate-cancer-analyses-of-the-randomized
#8
JOURNAL ARTICLE
Fred Saad, Maha H A Hussain, Bertrand Tombal, Karim Fizazi, Cora N Sternberg, E David Crawford, Luke T Nordquist, Martin Bögemann, Ronald Tutrone, Neal D Shore, Laurence Belkoff, Todd Fralich, Jay Jhaveri, Shankar Srinivasan, Rui Li, Frank Verholen, Iris Kuss, Matthew R Smith
BACKGROUND AND OBJECTIVE: Addition of darolutamide to androgen deprivation therapy (ADT) and docetaxel significantly improved overall survival (OS) in ARASENS (NCT02799602). Here we report on prostate-specific antigen (PSA) responses and their association with outcomes. METHODS: ARASENS is an international, double-blind, phase 3 study in patients with metastatic hormone-sensitive prostate cancer (mHSPC) randomized to darolutamide 600 mg orally twice daily (n = 651) or placebo (n = 654), both with ADT + docetaxel...
April 20, 2024: European Urology
https://read.qxmd.com/read/38644109/preoperative-risk-calculator-for-the-probability-of-completing-nephron-sparing-for-kidney-cancer
#9
JOURNAL ARTICLE
Francesco Cei, Alessandro Larcher, Giuseppe Rosiello, Giuseppe Basile, Giacomo Musso, Chiara Re, Giuseppe Fallara, Federico Belladelli, Giorgio Brembilla, Giorgia Guazzarotti, Francesco De Cobelli, Laura Marandino, Andrea Necchi, Alberto Briganti, Andrea Salonia, Roberto Bertini, Francesco Montorsi, Umberto Capitanio
PURPOSE: In absence of predictive models, preoperative estimation of the probability of completing partial (PN) relative to radical nephrectomy (RN) is invariably inaccurate and subjective. We aimed to develop an evidence-based model to assess objectively the probability of PN completion based on patients' characteristics, tumor's complexity, urologist expertise and surgical approach. DESIGN, SETTING AND PARTICIPANTS: 675 patients treated with PN or RN for cT1-2 cN0 cM0 renal mass by seven surgeons at one single experienced centre from 2000 to 2019...
April 21, 2024: Urologic Oncology
https://read.qxmd.com/read/38643347/single-port-robot-assisted-radical-prostatectomy
#10
REVIEW
Nicolas A Soputro, Jihad Kaouk
PURPOSE: To provide a comprehensive update on the different techniques and outcomes of contemporary Single-Port (SP) Robotic Radical Prostatectomy (RARP) approaches. METHODS: A literature review was performed to identify cohort studies that have utilized the purpose-built SP robotic platform (Intuitive Surgical Inc., Sunnyvale, California) for RARP. All published approaches of SP-RARP were included in our review. Baseline clinical, perioperative, and postoperative oncological and functional outcomes were collected from the included studies...
April 20, 2024: World Journal of Urology
https://read.qxmd.com/read/38643097/the-effects-of-different-positions-on-lower-extremity-hemodynamics-during-robot-assisted-laparoscopic-radical-prostatectomy-for-prostate-cancer
#11
JOURNAL ARTICLE
Zheng Wang, Xinyu Wang, Xiaofen Yu
PURPOSE: This study aimed to investigate the effects of two different positions on lower extremity hemodynamics during robot-assisted laparoscopic radical prostatectomy (RARP) for prostate cancer. METHODS: A total of 196 patients who underwent RARP in our hospital from February 2020 to March 2022 were included in this study. Among them, 98 patients who underwent surgery with the Trendelenburg position and split-leg position with calf reverse arch from March 2021 to March 2022 were assigned to the observation group, while 98 patients who underwent surgery with the Trendelenburg position and low lithotomy position from February 2020 to February 2021 were assigned to the control group...
April 20, 2024: BMC Urology
https://read.qxmd.com/read/38642931/preoperative-three-dimensional-modelling-and-virtual-reality-planning-aids-nephron-sparing-surgery-in-a-child-with-bilateral-wilms-tumour
#12
JOURNAL ARTICLE
Avijit Banerjee, Ramesh Babu, Dhaarani Jayaraman, Srinivas Chilukuri
Bilateral Wilms tumour (BWT) is a surgically challenging condition. Virtual reality (VR) reconstruction aids surgeons to foresee the anatomy ahead of Nephron Sparing Surgery (NSS). Three-dimensional (3D) visualisation improves the anatomical orientation of surgeons performing NSS. We herewith report a case of BWT where VR planning and 3D printing were used to aid NSS. Conventional imaging is often found to be inadequate while assessing the tumour-organ-vascular anatomy. Advances like VR and 3D printing help surgeons plan better for complex surgeries like bilateral NSS...
April 19, 2024: BMJ Case Reports
https://read.qxmd.com/read/38642726/what-is-the-role-of-physical-exercise-in-the-era-of-cancer-prehabilitation-a-systematic-review
#13
REVIEW
Nicole Del Bianco, Anita Borsati, Linda Toniolo, Christian Ciurnielli, Lorenzo Belluomini, Jessica Insolda, Marco Sposito, Michele Milella, Federico Schena, Sara Pilotto, Alice Avancini
PURPOSE: Exercise before surgery, as part of prehabilitation, aiming to enhance patients' functional and physiological capacity, has become widespread, necessitating an in-depth understanding. METHODS: A systematic search was conducted on Pubmed, Cochrane, and Scopus to examine the effect of exercise as prehabilitation, alone or in combination with other interventions, in patients with cancer. Interventional studies applying a single-arm, randomized controlled, or nonrandomized design were included...
April 18, 2024: Critical Reviews in Oncology/hematology
https://read.qxmd.com/read/38642466/holmium-laser-enucleation-of-the-prostate-for-a-case-of-transition-zone-prostate-cancer
#14
JOURNAL ARTICLE
Michelle K Li, Orlando Diaz, Jonathan E Katz
Standard treatment approaches for localized prostate cancer remain limited to active surveillance, radiotherapy, and radical prostatectomy. We present a case of transition zone prostate cancer that was treated with holmium laser enucleation of the prostate, a procedure that is normally reserved for the management of benign prostatic hyperplasia.
April 2024: Canadian Journal of Urology
https://read.qxmd.com/read/38642465/urethral-carcinoma-after-skin-substitution-urethral-reconstruction
#15
JOURNAL ARTICLE
Zhan Wu, Mystie Chen, Ryan Mori
Urethral cancer after urethral reconstruction is an under-recognized, uncommon disease associated with significant morbidity and mortality. The survival rates of patients with carcinoma of the bulbar urethra are as low as 20%-30%. Stricture recurrence and unrecognized malignant changes present prior to reconstruction are major risk factors for urethral cancer. Skin substitution urethroplasty is subjected to higher rates of recurrence, which lends to the potential for carcinogenesis. We present a case of a 59-year-old male who underwent multi-stage skin substitution urethroplasty who developed urethral carcinoma 20 years later...
April 2024: Canadian Journal of Urology
https://read.qxmd.com/read/38642459/optimizing-outcomes-in-men-with-prostate-cancer-the-cardiovascular-event-lowering-caelo-pathways
#16
JOURNAL ARTICLE
David E Crawford, David Albala, Marc B Garnick, Andrew W Hahn, Paul Maroni, Rana R McKay, Martin Miner, Peter Orio Ⅲ, Kshitij Pandit, Scott Sellinger, Evan Y Yu, Robert H Eckel
INTRODUCTION: Risk of cardiovascular disease is higher among men with prostate cancer than men without, and prostate cancer treatments (especially those that are hormonally based) are associated with increased cardiovascular risk. MATERIALS AND METHODS: An 11-member panel of urologic, medical, and radiation oncologists (along with a men's health specialist and an endocrinologist/preventive cardiologist) met to discuss current practices and challenges in the management of cardiovascular risk in prostate cancer patients who are taking androgen deprivation therapies (ADT) including LHRH analogues, alone and in combination with androgen-targeted therapies (ATTs)...
April 2024: Canadian Journal of Urology
https://read.qxmd.com/read/38642457/is-psma-pet-disrupting-traditional-prostate-cancer-staging-and-treatment
#17
EDITORIAL
Leonard G Gomella
No abstract text is available yet for this article.
April 2024: Canadian Journal of Urology
https://read.qxmd.com/read/38641982/penile-carcinoma-a-retrospective-analysis-of-93-patients-at-a-tertiary-care-center-in-jakarta-indonesia
#18
JOURNAL ARTICLE
Mega Anara Manurung, Rainy Umbas, Agus Rizal A H Hamid, Chaidir Arif Mochtar
OBJECTIVES: Penile carcinoma (PC) is a rare disease with considerable physical and psychological impact. To date, there is no data regarding PC prevalence and characteristics in Indonesia. This study aimed to analyze the characteristics of patients with PC in Indonesia and determine cumulative survival rates and time to disease progression. METHODS: This was a retrospective study of all patients diagnosed with PC at Cipto Mangunkusumo General Hospital from 1995 to 2014, with a minimum of 1 year follow-up...
April 20, 2024: International Journal of Urology: Official Journal of the Japanese Urological Association
https://read.qxmd.com/read/38641541/prognostic-significance-of-immune-cell-infiltration-in-muscle-invasive-bladder-cancer-treated-with-definitive-chemoradiation-a-secondary-analysis-of-rtog-0524-and-rtog-0712
#19
JOURNAL ARTICLE
Zaker Rana, Sophia C Kamran, Amol C Shetty, Philip Sutera, Yang Song, Soha Bazyar, Abhishek A Solanki, Jeffry P Simko, Alan Pollack, David McConkey, Max Kates, M Minhaj Siddiqui, Jeffrey Hiken, Jon Earls, David Messina, Kent W Mouw, David Miyamoto, William U Shipley, M Dror Michaelson, Anthony Zietman, John J Coen, Douglas M Dahl, Ashesh B Jani, Luis Souhami, Brian K Chang, R Jeffrey Lee, Huong Pham, David T Marshall, Xinglei Shen, Stephanie L Pugh, Felix Y Feng, Jason A Efstathiou, Phuoc T Tran, Matthew P Deek
Chemoradiation therapy (CRT) is a treatment for muscle-invasive bladder cancer (MIBC). Using a novel transcriptomic profiling panel, we validated prognostic immune biomarkers to CRT using 70 pretreatment tumor samples from prospective trials of MIBC (NRG/RTOG 0524 and 0712). Disease-free survival (DFS) and overall survival (OS) were estimated via the Kaplan-Meier method and stratified by genes correlated with immune cell activation. Cox proportional-hazards models were used to assess group differences. Clustering of gene expression profiles revealed that the cluster with high immune cell content was associated with longer DFS (hazard ratio [HR] 0...
April 18, 2024: European Urology Oncology
https://read.qxmd.com/read/38641474/natural-history-and-health-care-burden-of-non-curative-treatment-for-muscle-invasive-bladder-cancer
#20
JOURNAL ARTICLE
Haim Herzberg, Yossi Ventura, Karin Lifshitz, Ziv Savin, Shay Golan, Jack Baniel, Ofer Yossepowitch, Roy Mano
OBJECTIVE: Muscle-invasive bladder cancer is an aggressive disease. Yet, many patients, especially those with advanced age and multiple comorbidities, do not receive treatment with curative intent. We evaluated the disease course and health care burden of these patients. MATERIALS AND METHODS: Bi-center, retrospective analysis of patients diagnosed with muscle-invasive bladder cancer who did not undergo curative-intent treatment (radical cystectomy or trimodal therapy) between 2016 and 2021...
April 18, 2024: Urologic Oncology
keyword
keyword
75195
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.